The effects are indirect they come from how the medication changes your mouths environment, not from the drug touching your teeth
Studies have found that higher doses can further reduce glycosylated hemoglobin and body weight, and the safety is similar to low doses
Chan HW, Cheung CY, Liu YL, Chan YH, Wong HS, Chak WL, et al
The development of small molecule oral agonists could revolutionize the landscape of GLP-1 therapies, improving patient compliance and ultimately leading to better health outcomes
However, individuals with medical conditions or sensitivities should consult a healthcare professional first
The bad news is, stress, aging, toxins around us, poor nutrition, and illness can lower your glutathione levels